[go: up one dir, main page]

WO2003028768A1 - Traitements - Google Patents

Traitements Download PDF

Info

Publication number
WO2003028768A1
WO2003028768A1 PCT/JP2002/009312 JP0209312W WO03028768A1 WO 2003028768 A1 WO2003028768 A1 WO 2003028768A1 JP 0209312 W JP0209312 W JP 0209312W WO 03028768 A1 WO03028768 A1 WO 03028768A1
Authority
WO
WIPO (PCT)
Prior art keywords
remedies
sugar chain
chain modification
preventives
diseases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/JP2002/009312
Other languages
English (en)
Japanese (ja)
Inventor
Nobuto Koyama
Ikunoshin Kato
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takara Bio Inc
Original Assignee
Takara Bio Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takara Bio Inc filed Critical Takara Bio Inc
Publication of WO2003028768A1 publication Critical patent/WO2003028768A1/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/45—Transferases (2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hospice & Palliative Care (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Psychiatry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

L'invention concerne des traitements préventifs ou curatifs de maladies nécessitant une modification de la chaîne des sucres, caractérisés en ce qu'ils contiennent un gène qui code pour une enzyme intervenant dans la modification de la chaîne des sucres.
PCT/JP2002/009312 2001-09-12 2002-09-12 Traitements Ceased WO2003028768A1 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2001-277238 2001-09-12
JP2001277238 2001-09-12
JP2001-305749 2001-10-01
JP2001305749 2001-10-01

Publications (1)

Publication Number Publication Date
WO2003028768A1 true WO2003028768A1 (fr) 2003-04-10

Family

ID=26622092

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2002/009312 Ceased WO2003028768A1 (fr) 2001-09-12 2002-09-12 Traitements

Country Status (1)

Country Link
WO (1) WO2003028768A1 (fr)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995026200A1 (fr) * 1994-03-25 1995-10-05 Indiana University Foundation Transfert d'adn par mediation virale renforcee
US5874271A (en) * 1992-08-21 1999-02-23 Takara Shuzo Co., Ltd. Human glycosyltransferase gene, compounds and method for inhibiting cancerous metastasis
US6153433A (en) * 1995-11-17 2000-11-28 Takara Shuzo Co., Ltd. Inhibitor for viral replication

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5874271A (en) * 1992-08-21 1999-02-23 Takara Shuzo Co., Ltd. Human glycosyltransferase gene, compounds and method for inhibiting cancerous metastasis
WO1995026200A1 (fr) * 1994-03-25 1995-10-05 Indiana University Foundation Transfert d'adn par mediation virale renforcee
US6153433A (en) * 1995-11-17 2000-11-28 Takara Shuzo Co., Ltd. Inhibitor for viral replication

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
KENKO KUBUSHIRO ET AL.: "Tokushu/shikuygan eno approach - Keitai to bunshi saibo seibutsugaku yori - Bunshi hyoteki to shite no to ten'i koso idenshi to shikyutai gan saibo no tokusei", SANFUJINKA NO SEKAI, vol. 52, no. 7, 1 July 2000 (2000-07-01), pages 621 - 629, XP002961357 *
MIYOSHI EIJI ET AL.: "Transfection of N-acetylglucosaminyl-transferase III gene suppresses expression of hepatitis B virus in a human hepatoma cell line, HB611", THE JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 270, no. 47, 24 November 1995 (1995-11-24), pages 28311 - 28315, XP002961356 *
TANIGUCHI, NAOYUKI ET AL.: "Implications of N-acetylglucose-aminyltransferases III and V in cancer: gene regulation and signaling mechanism", BIOCHIMICA ET BIOPHYSICA ACTA, vol. 1455, no. 2-3, 8 October 1999 (1999-10-08), pages 287 - 300, XP004276913 *
YOSHIMURA MASAFUMI ET AL.: "Suppression of lung metastasis of B16 mouse melanoma by N-acetylglucosaminyltransferase III gene transfection", PROC. NATL. ACAD. SCI. USA, vol. 92, no. 19, 12 September 1995 (1995-09-12), pages 8754 - 8758, XP002961355 *

Similar Documents

Publication Publication Date Title
AU2003294229A1 (en) Sliver type autonomous biosensors
WO2006023081A3 (fr) Articles ceramiques et procede de fabrication et d'utilisation
WO2004033668A8 (fr) Proteases, acides nucleiques les codant et leurs procedes de fabrication et d'utilisation
WO2003083054A9 (fr) Amylases, acides nucleiques les codant et procedes de fabrication et d'utilisation correspondants
AU2003228952A1 (en) Automated online underwriting
AU2003238324A1 (en) Multiple game block assembly
AU2001227900A1 (en) Drug metabolizing enzymes
AU2003229184A1 (en) Retro-mechanical, post-mechanical, bi-mechanical traction engines
AU2001270303A1 (en) Drug metabolizing enzymes
AU2002347778A1 (en) Enzymes
AU2002312624A1 (en) Drug metabolizing enzymes
AU2003234809A1 (en) Optical transmission mediums, and processes and apparutus for producing optical transmission mediums
AU2003253745A1 (en) Card connector with selective card stop mechanism
WO2003028768A1 (fr) Traitements
AU2001255324A1 (en) Drug metabolizing enzymes
AU2001235000A1 (en) Drug metabolizing enzymes
AU2003296961A1 (en) Targeted invitation delivery
WO2003057712A3 (fr) Lactoferrine humanisee et utilisations de celle-ci
AU2002329931A1 (en) Salvianolic acid b
AU2001278154A1 (en) Drug metabolizing enzymes
AU2003245747A1 (en) Enzymes
WO2003064653A3 (fr) Procede de sur-expression de dehydrogenases
WO2003014156A3 (fr) Isoformes de neureguline-$g(b) associes a des processus neuronaux
AU2002257273A1 (en) Enzymes
AUPR246301A0 (en) F.l.o.e.s, s.p.l.s.d

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BY BZ CA CH CN CO CR CU CZ DE DM DZ EC EE ES FI GB GD GE GH HR HU ID IL IN IS JP KE KG KR KZ LK LR LS LT LU LV MA MD MG MK MW MX MZ NO NZ OM PH PL PT RO SD SE SG SI SK SL TJ TM TN TR TT UA UG US UZ VC VN YU ZA ZM

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ UG ZM ZW AM AZ BY KG KZ RU TJ TM AT BE BG CH CY CZ DK EE ES FI FR GB GR IE IT LU MC PT SE SK TR BF BJ CF CG CI GA GN GQ GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP